Regional citrate anticoagulation for RRTs in critically Ill patients with AKI

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 12, 2014, Pages 2173-2188

  Morabito, Santo ^a   Pistolesi, Valentina ^a   Tritapepe, Luigi ^b   Fiaccadori, Enrico ^c  

^a Department of Nephrology and Urology Hemodialysis Unit   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACID CITRATE DEXTROSE; CALCIUM; CITRATE TRISODIUM; CITRIC ACID; DIALYSIS FLUID; LACTIC ACID; MAGNESIUM; SODIUM; ANTICOAGULANT AGENT; HYPERTONIC SOLUTION; ISOTONIC SOLUTION;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; BONE METABOLISM; CONCENTRATION (PARAMETERS); CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; CRITICALLY ILL PATIENT; DIALYSIS; DISEASE ASSOCIATION; ELECTROLYTE BALANCE; EXTRACORPOREAL CIRCULATION; HEMODYNAMICS; HOSPITAL COST; HUMAN; HYPERCALCEMIA; HYPERNATREMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPONATREMIA; INFUSION SYSTEM; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; REGIONAL CITRATE ANTICOAGULATION; RENAL REPLACEMENT THERAPY; TRANSFUSION; ACUTE KIDNEY INJURY; BLOOD FLOW; CRITICAL ILLNESS; DRUG EFFECTS; HEMORRHAGE; METABOLISM; PROCEDURES;

ACUTE KIDNEY INJURY; ANTICOAGULANTS; CITRATES; CRITICAL ILLNESS; DIALYSIS SOLUTIONS; HEMORRHAGE; HUMANS; HYPERTONIC SOLUTIONS; ISOTONIC SOLUTIONS; REGIONAL BLOOD FLOW; RENAL REPLACEMENT THERAPY; WATER-ELECTROLYTE BALANCE;

EID: 84923925678     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01280214     Document Type: Article

References (105)

1. Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A: Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int 59: 1510–1519, 2001
2. Mehta RL: Anticoagulation during continuous renal replacement therapy. ASAIO J 40: 931–935, 1994
3. van deWetering J, Westendorp RG, van derHoeven JG, Stolk B, Feuth JD, Chang PC: Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 7: 145–150, 1996
4. Ward DM, Mehta RL: Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int Suppl 41: S237–S244, 1993
5. Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL: Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). NephrolDial Transplant 20: 1416–1421, 2005
6. Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR: Anticoagulation strategies in continuous renal replacement therapy: Can the choice be evidence based? Intensive CareMed 32: 188–202, 2006
7. Tolwani AJ, Wille KM: Anticoagulation for continuous renal replacement therapy. Semin Dial 22: 141–145, 2009
8. Tan HK, Baldwin I, Bellomo R: Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 26: 1652–1657, 2000
9. Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A: Continuous renal replacement therapies: Anticoagulation in the critically ill at high risk of bleeding. J Nephrol 16: 566–571, 2003
10. Oudemans-van Straaten HM, Ostermann M: Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice. Crit Care 16: 249, 2012
11. Tolwani A, Wille KM: Advances in continuous renal replacement therapy: Citrate anticoagulation update. Blood Purif 34: 88–93, 2012
12. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P; VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20, 2008
13. Joannidis M, Oudemans-van Straaten HM: Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 11: 218, 2007
14. Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, Pierucci A: Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: A continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care 16: R111, 2012
15. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 30: 260–265, 2004
16. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 67: 2361–2367, 2005
17. Betjes MG, vanOosterom D, van Agteren M, van deWetering J: Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: Similar hemofilter survival but significantly less bleeding. J Nephrol 20: 602–608, 2007
18. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF: Citrate anticoagulation for continuous venovenous hemo- filtration. Crit Care Med 37: 545–552, 2009
19. Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC: Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: A prospective randomized multicentre trial. Nephrol Dial Transplant 26: 232–239, 2011
20. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney InjuryWork Group: KDIGOClinical Practice Guideline for Acute Kidney Injury. Kidney Int [Suppl 2]: 1–138, 2012
21. James M, Bouchard J, Ho J, Klarenbach S, LaFrance JP, Rigatto C, Wald R, Zappitelli M, Pannu N: Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61: 673–685, 2013
22. Davenport A, Tolwani A: Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus 2: 439–447, 2009
23. Abramson S, Niles JL: Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 8: 701–707, 1999
24. Böhler J, Schollmeyer P, Dressel B, Dobos G, Hörl WH: Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: Dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 7: 234–241, 1996
25. Bos JC, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nube´ MJ: Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis. Nephrol Dial Transplant 12: 1387–1393, 1997
26. Dhondt A, Vanholder R, Tielemans C, Glorieux G, Waterloos MA, De Smet R, Lameire N: Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes. Nephron 85: 334–342, 2000
27. Gabutti L, Ferrari N, Mombelli G, Keller F, Marone C: The favorable effect of regional citrate anticoagulation on interleukin- 1beta release is dissociated from both coagulation and complement activation. J Nephrol 17: 819–825, 2004
28. Gritters M, Grooteman MP, Schoorl M, Schoorl M, Bartels PC, Scheffer PG, Teerlink T, Schalkwijk CG, Spreeuwenberg M, Nube´ MJ: Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 21: 153–159, 2006
29. Schilder L, Nurmohamed SA, ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB: Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients. BMC Nephrol 15: 19, 2014
30. Bryland A, Wieslander A, Carlsson O, Hellmark T, Godaly G: Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions. Diab Vasc Dis Res 9: 42–51, 2012
31. Iacobazzi V, Infantino V: Citrate - new functions for an old metabolite. Biol Chem 395: 387–399, 2014
32. Oudemans-van Straaten HM, Kellum JA, Bellomo R: Clinical review: Anticoagulation for continuous renal replacement therapy—heparin or citrate? Crit Care 15: 202, 2011
33. Swartz R, Pasko D, O’Toole J, Starmann B: Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 61: 134–143, 2004
34. Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, Tetta C, Dellavalle A, Stella M, Triolo G: Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant 26: 3882–3888, 2011
35. White RD, Goldsmith RS, Rodriguez R, Moffitt EA, Pluth JR: Plasma ionic calcium levels following injection of chloride, gluconate, and gluceptate salts of calcium. J Thorac Cardiovasc Surg 71: 609–613, 1976
36. Martin TJ, Kang Y, Robertson KM, Virji MA, Marquez JM: Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function. Anesthesiology 73: 62–65, 1990
37. Morgan DJ, Ho KM: Profound hypocalcaemia in a patient being anticoagulated with citrate for continuous renal replacement therapy. Anaesthesia 64: 1363–1366, 2009
38. Vanholder R, Sever MS, Erek E, Lameire N: Rhabdomyolysis. J Am Soc Nephrol 11: 1553–1561, 2000
39. Brain M, Anderson M, Parkes S, Fowler P: Magnesium flux during continuous venovenous haemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc 14: 274–282, 2012
40. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit CareMed 31: 2450–2455, 2003
41. Zheng Y, Xu Z, Zhu Q, Liu J, Qian J, You H, Gu Y, Hao C, Jiao Z, Ding F: Citrate pharmacokinetics in critically ill patients with acute kidney injury. PLoS ONE 8: e65992, 2013
42. Balik M, Zakharchenko M, Leden P, Otahal M, Hruby J, Polak F, Rusinova K, Stach Z, Tokarik M, Vavrova J, Jabor A, Oudemans-van Straaten HM: Bioenergetic gain of citrate anticoagulated continuous hemodiafiltration—a comparison between 2 citratemodalities and unfractionated heparin. J Crit Care 28: 87–95, 2013
43. Fiaccadori E, Regolisti G, Maggiore U: Specialized nutritional support interventions in critically ill patients on renal replacement therapy. Curr Opin Clin Nutr Metab Care 16: 217–224, 2013
44. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29: 748–752, 2001
45. Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer HH, Peters H, Slowinski T: Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysiswith regional citrate anticoagulation. J Crit Care 29: 265–271, 2014
46. Morgera S, Schneider M, Slowinski T, Vargas-Hein O, Zuckermann-Becker H, Peters H, Kindgen-Milles D, Neumayer HH: A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 37: 2018–2024, 2009
47. Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G: Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 36: 1735–1743, 2010
48. Link A, Klingele M, Speer T, Rbah R, Pöss J, Lerner-Gräber A, Fliser D, Böhm M: Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care 16: R97, 2012
49. Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D: Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Ther Apher Dial 17: 202–212, 2013
50. Nurmohamed SA, Jallah BP, Vervloet MG, Yldirim G, ter Wee PM, Groeneveld AB: Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: A prospective observational study. BMC Nephrol 14: 89, 2013
51. Fiaccadori E, Regolisti G, Cademartiri C, Cabassi A, Picetti E, Barbagallo M, Gherli T, Castellano G, Morabito S, Maggiore U: Efficacy and safety of a citrate-based protocol for sustained lowefficiency dialysis in AKI using standard dialysis equipment. Clin J Am Soc Nephrol 8: 1670–1678, 2013
52. Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD Jr.: Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 33: e8, 1999
53. Schultheiß C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwächter H, Schmid RM, Huber W: Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: A prospective observational study. Crit Care 16: R162, 2012
54. Hetzel GR, Taskaya G, Sucker C, Hennersdorf M, Grabensee B, Schmitz M: Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. AmJ Kidney Dis 48: 806–811, 2006
55. Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH: Detection of citrate overdose in critically ill patients on citrateanticoagulated venovenous haemofiltration: Use of ionised and total/ionised calcium. Clin Chem Lab Med 44: 962–966, 2006
56. Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, Bacher A: Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 39: 273–279, 2011
57. Saner FH, Treckmann JW, Geis A, Lösch C, Witzke O, Canbay A, Herget-Rosenthal S, Kribben A, Paul A, Feldkamp T: Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant 27: 1651–1657, 2012
58. Meijers B, Laleman W, Vermeersch P, Nevens F, Wilmer A, Evenepoel P: A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System. Crit Care 16: R20, 2012
59. Bouchard J, Madore F: Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy. NDT Plus 2: 11–19, 2009
60. Morita Y, Johnson RW, Dorn RE, Hall DS: Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 242: 32–43, 1961
61. Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38: 976–981, 1990
62. Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM: A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 1: 79–87, 2006
63. Cubattoli L, Teruzzi M, Cormio M, Lampati L, Pesenti A: Citrate anticoagulation during CVVH in high risk bleeding patients. Int J Artif Organs 30: 244–252, 2007
64. Shum HP, Chan KC, Yan WW: Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution. Ther Apher Dial 16: 81–86, 2012
65. Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A: Regional citrate anticoagulation in CVVH: A new protocol combining citrate solution with a phosphate-containing replacement fluid. Hemodial Int 17: 313–320, 2013
66. Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A: Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: Effects on acid-base status and phosphate supplementation needs. BMC Nephrol 14: 232, 2013
67. Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, Fiaccadori E, Pierucci A: Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation. Int J Artif Organs 36: 845–852, 2013
68. Tobe SW, Aujla P, Walele AA, Oliver MJ, Naimark DM, Perkins NJ, Beardsall M: A novel regional citrate anticoagulation protocol for CRRTusing only commercially available solutions. J Crit Care 18: 121–129, 2003
69. Munjal S, Ejaz AA: Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations. Nephrology (Carlton) 11: 405–409, 2006
70. Zhang Z, Hongying N: Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive CareMed 38: 20–28, 2012
71. Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW: Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: A meta-analysis of randomized controlled trials. Am J Kidney Dis 59: 810–818, 2012
72. Fliser D, Kielstein JT: Technology insight: Treatment of renal failure in the intensive care unitwith extended dialysis. Nat Clin Pract Nephrol 2: 32–39, 2006
73. Mariano F, Pozzato M, Canepari G, Vitale C, Bermond F, Sacco C, Amore A, Manes M, Navino C; Piedmont and Aosta Valley Section of Italian Society of Nephrology: Renal replacement therapy in intensive care units: A survey of nephrological practice in northwest Italy. J Nephrol 24: 165–176, 2011
74. Marshall MR, Golper TA: Low-efficiency acute renal replacement therapy: Role in acute kidney injury. Semin Dial 24: 142–148, 2011
75. Marshall MR, Creamer JM, Foster M, Ma TM, Mann SL, Fiaccadori E, Maggiore U, Richards B, Wilson VL, Williams AB, Rankin AP: Mortality rate comparison after switching from continuous to prolonged intermittent renal replacement for acute kidney injury in three intensive care units from different countries. Nephrol Dial Transplant 26: 2169–2175, 2011
76. Schwenger V, Weigand MA, Hoffmann O, Dikow R, Kihm LP, Seckinger J, Miftari N, Schaier M, Hofer S, Haar C, Nawroth PP, Zeier M, Martin E, Morath C: Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: The REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care 16: R140, 2012
77. Fieghen HE, Friedrich JO, Burns KE, Nisenbaum R, Adhikari NK, Hladunewich MA, Lapinsky SE, Richardson RM, Wald R; University of Toronto Acute Kidney Injury Research Group: The hemodynamic tolerability and feasibility of sustained low effi- ciency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol 11: 32, 2010
78. Kron J, Kron S, Wenkel R, Schuhmacher HU, Thieme U, Leimbach T, Kern H, Neumayer HH, Slowinski T: Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: Awell-tolerated and feasible procedure. Nephrol Dial Transplant 27: 146–152, 2012
79. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D: Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: A randomized controlled study. Am J Kidney Dis 43: 342–349, 2004
80. Fiaccadori E, Maggiore U, Parenti E, Giacosa R, Picetti E, Rotelli C, Tagliavini D, Cabassi A: Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patientswith acute renal failure. Nephrol Dial Transplant 22: 529–537, 2007
81. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK: Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 60: 777–785, 2001
82. Oudemans-Van Straaten HM: Review and guidelines for regional anticoagulation with citrate in continuous hemofiltration. Neth J Crit Care 8: 146–156, 2004
83. Kumar VA, Craig M, Depner TA, Yeun JY: Extended daily dialysis: A new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis 36: 294–300, 2000
84. Marshall MR, Ma T, Galler D, Rankin AP, Williams AB: Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: Towards an adequate therapy. Nephrol Dial Transplant 19: 877–884, 2004
85. Berbece AN, Richardson RM: Sustained low-efficiency dialysis in the ICU: Cost, anticoagulation, and solute removal. Kidney Int 70: 963–968, 2006
86. Clark JA, Schulman G, Golper TA: Safety and efficacy of regional citrate anticoagulation during 8-hour sustained lowefficiency dialysis. Clin J Am Soc Nephrol 3: 736–742, 2008
87. Szamosfalvi B, Frinak S, Yee J: Automated regional citrate anticoagulation: Technological barriers and possible solutions. Blood Purif 29: 204–209, 2010
88. Fiaccadori E, Lombardi M, Leonardi S, Rotelli CF, Tortorella G, Borghetti A: Prevalence and clinical outcome associated with preexisting malnutrition in acute renal failure: A prospective cohort study. J Am Soc Nephrol 10: 581–593, 1999
89. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26–30, 2000
90. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305–310, 2002
91. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial. Crit Care Med 30: 2205–2211, 2002
92. Fall P, Szerlip HM: Continuous renal replacement therapy: Cause and treatment of electrolyte complications. Semin Dial 23: 581–585, 2010
93. Apsner R, Gruber D, Ho¨ rl WH, Sunder-Plassmann G: Parathyroid hormone secretion during citrate anticoagulated hemodialysis in acutely ill maintenance hemodialysis patients. Anesth Analg 99: 1199–1204, 2004
94. van der Voort PH, Postma SR, Kingma WP, Boerma EC, de Heide LJ, Bakker AJ: An observational study on the effects of nadroparinbased and citrate-based continuous venovenous hemofiltration on calcium metabolism. Blood Purif 25: 267–273, 2007
95. Brain M, Parkes S, Fowler P, Robertson I, Brown A: Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc 13: 72–81, 2011
96. Wang PL, Meyer MM, Orloff SL, Anderson S: Bone resorption and “relative” immobilization hypercalcemia with prolonged continuous renal replacement therapy and citrate anticoagulation. Am J Kidney Dis 44: 1110–1114, 2004
97. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA: Continuous renal replacement therapy: A worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 33: 1563–1570, 2007
98. Morabito S, Pistolesi V, Pierucci A: Regional citrate anticoagulation: Towards a first-choice treatment. G Ital Nefrol 29: 14–19, 2012
99. Liet JM, Allain-Launay E, Gaillard-Leroux B, Barriére F, Chenouard A, Dejode JM, Joram N: Regional citrate anticoagulation for pediatric CRRTusing integrated citrate software and physiological sodium concentration solutions [published online ahead of print February 15, 2014]. Pediatr Nephrol 10.1007/s00467-014-2770-2
100. Thijssen S, Kruse A, Raimann J, Bhalani V, Levin NW, Kotanko P: A mathematical model of regional citrate anticoagulation in hemodialysis. Blood Purif 29: 197–203, 2010
101. Brandl M, Strobl K, Hartmann J, Kellner K, Posnicek T, Falkenhagen D: A target-orientated algorithm for regional citrate-calcium anticoagulation in extracorporeal therapies. Blood Purif 33: 7–20, 2012
102. Strobl K, Hartmann J, Wallner M, Brandl M, Falkenhagen D: A target-oriented algorithm for citrate-calcium anticoagulation in clinical practice. Blood Purif 36: 136–145, 2013
103. Gupta M, Wadhwa NK, Bukovsky R: Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. AmJ Kidney Dis 43: 67–73, 2004
104. Park JS, Kim GH, Kang CM, Lee CH: Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration. Korean J Intern Med 26: 68–75, 2011
105. Morgera S, Scholle C, Melzer C, Slowinski T, Liefeld L, Baumann G, Peters H, Neumayer HH: A simple, safe and effective citrate anticoagulation protocol for the genius dialysis system in acute renal failure. Nephron Clin Pract 98: c35–c40, 2004